Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1241-2025

Optima MR360, NMRI system Recall

Optima MR360, NMRI system

FDA recall Class II

Ongoing

FDA lists this Class II recall for Optima MR360, NMRI system. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1241-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jan 31, 2025
FDA report date
Mar 5, 2025
Quantity in commerce
33
Distribution
See key details
FDA cause
Software design

What is being recalled?

Optima MR360, NMRI system

Affected model & UDI checker

Search the exact identifiers published for Z-1241-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedOptima MR360, NMRI systemCheck source notice00840682113762
FDA code information

A. UDI-DI 00840682113762 System ID 0910274038 B. No UDI-DI System IDs 082427040134 082427040185 082427060043 082427070088 082427070093 082427070099 082427100174 082427100178 082427100197 082427120140 082427140095 082427220046 082427270041 082427310088 082427310092 083027288790310 0856270061 AE1373MR01 DZ1339MR03 FI1432MR01 H4678MR04 MRR9282 MRR9877 PL2059MR01 PL2433MR01 RU3338MR03 SA1056MR03 SA2191MR04 SA2253MR01 SA2352MR01 TN1008MR01 TN1241MR01 34352MRS01 (Update 12/29/25 - Additional System IDs 83027809699615, LV4026MR01) (Update 1/28/26 - Additional System ID 82427190104)

View the original FDA recall notice

Why was this product recalled?

For certain MR systems, a scan can be resumed following a Power Monitor trip when the "6-minute average SAR" is above the limit indicated on the "SAR Display". The user interface may incorrectly enable a scan to proceed earlier than intended. If resumed by the operator, such a scan can result in potential excessive tissue heating, especially if the patient is in contact with a conductive material or has an implant.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did GE Healthcare (China) Co., Ltd. take?

On January 31, 2025, the firm notified customers through Urgent Medical Device Correction letters. Customers were provided with instructions for continued use of their MR systems. All potential users should be made aware of this safety notification and recommended actions. If you have any questions or concerns regarding this notification, please contact GE HealthCare Service at 1-800-437-1171 or your local Service Representative.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA classification recorded

  3. FDA notice posted

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology